We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to CVS Health (CVS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts expect CVS Health (CVS - Free Report) to post quarterly earnings of $1.62 per share in its upcoming report, which indicates a year-over-year increase of 1.3%. Revenues are expected to be $105.04 billion, up 2.1% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some CVS Health metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Revenue- Health Care Benefits' at $35.86 billion. The estimate indicates a change of -0.4% from the prior-year quarter.
Analysts expect 'Net revenue- Health Services segment' to come in at $51.75 billion. The estimate points to a change of +5% from the year-ago quarter.
Analysts forecast 'Revenue- Pharmacy & Consumer Wellness Segment' to reach $35.51 billion. The estimate points to a change of -1.9% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Health Care Benefits Segment- Services' should come in at $1.86 billion. The estimate suggests a change of +7% year over year.
The collective assessment of analysts points to an estimated 'Medical membership - Total' of 25.99 million. The estimate is in contrast to the year-ago figure of 26.70 million.
It is projected by analysts that the 'Medical membership - Insured - Commercial' will reach 2.47 million. Compared to the current estimate, the company reported 3.54 million in the same quarter of the previous year.
The consensus estimate for 'Medical membership - Insured - Medicare Supplement' stands at $1.18 billion. The estimate compares to the year-ago value of $1.22 billion.
The combined assessment of analysts suggests that 'Medical membership - Medicaid - Total' will likely reach $2.31 billion. Compared to the current estimate, the company reported $2.37 billion in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Medical membership - ASC - Commercial' should arrive at 15.83 million. Compared to the present estimate, the company reported 15.31 million in the same quarter last year.
The consensus among analysts is that 'Medical benefit ratio (MBR)' will reach 92.4%. The estimate compares to the year-ago value of 92.8%.
Analysts predict that the 'Medical membership - Commercial - Total' will reach 18.30 million. The estimate is in contrast to the year-ago figure of 18.85 million.
Analysts' assessment points toward 'Medical membership - Medicare Advantage - Total' reaching 4.20 million. The estimate is in contrast to the year-ago figure of 4.27 million.
Shares of CVS Health have experienced a change of +6% in the past month compared to the +0.7% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CVS is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Countdown to CVS Health (CVS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Wall Street analysts expect CVS Health (CVS - Free Report) to post quarterly earnings of $1.62 per share in its upcoming report, which indicates a year-over-year increase of 1.3%. Revenues are expected to be $105.04 billion, up 2.1% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some CVS Health metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Revenue- Health Care Benefits' at $35.86 billion. The estimate indicates a change of -0.4% from the prior-year quarter.
Analysts expect 'Net revenue- Health Services segment' to come in at $51.75 billion. The estimate points to a change of +5% from the year-ago quarter.
Analysts forecast 'Revenue- Pharmacy & Consumer Wellness Segment' to reach $35.51 billion. The estimate points to a change of -1.9% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Health Care Benefits Segment- Services' should come in at $1.86 billion. The estimate suggests a change of +7% year over year.
The collective assessment of analysts points to an estimated 'Medical membership - Total' of 25.99 million. The estimate is in contrast to the year-ago figure of 26.70 million.
It is projected by analysts that the 'Medical membership - Insured - Commercial' will reach 2.47 million. Compared to the current estimate, the company reported 3.54 million in the same quarter of the previous year.
The consensus estimate for 'Medical membership - Insured - Medicare Supplement' stands at $1.18 billion. The estimate compares to the year-ago value of $1.22 billion.
The combined assessment of analysts suggests that 'Medical membership - Medicaid - Total' will likely reach $2.31 billion. Compared to the current estimate, the company reported $2.37 billion in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Medical membership - ASC - Commercial' should arrive at 15.83 million. Compared to the present estimate, the company reported 15.31 million in the same quarter last year.
The consensus among analysts is that 'Medical benefit ratio (MBR)' will reach 92.4%. The estimate compares to the year-ago value of 92.8%.
Analysts predict that the 'Medical membership - Commercial - Total' will reach 18.30 million. The estimate is in contrast to the year-ago figure of 18.85 million.
Analysts' assessment points toward 'Medical membership - Medicare Advantage - Total' reaching 4.20 million. The estimate is in contrast to the year-ago figure of 4.27 million.
View all Key Company Metrics for CVS Health here>>>Shares of CVS Health have experienced a change of +6% in the past month compared to the +0.7% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CVS is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .